Creative Planning - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,529
-99.4%
128
-99.3%
0.00%
-100.0%
Q2 2019$570,000
+21.3%
17,228
+28.3%
0.00%0.0%
Q1 2019$470,000
+60.4%
13,426
+52.2%
0.00%
+100.0%
Q4 2018$293,000
-71.9%
8,824
-57.3%
0.00%
-75.0%
Q3 2018$1,042,000
-16.0%
20,688
-0.1%
0.00%
-20.0%
Q2 2018$1,240,000
+66.0%
20,719
+27.1%
0.01%
+66.7%
Q1 2018$747,000
-15.1%
16,304
-26.2%
0.00%
-25.0%
Q4 2017$880,000
-12.1%
22,078
-11.8%
0.00%
-20.0%
Q3 2017$1,001,000
+27.2%
25,034
+37.1%
0.01%
+25.0%
Q2 2017$787,000
+130.8%
18,254
+67.4%
0.00%
+100.0%
Q1 2017$341,000
+337.2%
10,905
+251.8%
0.00%
Q4 2016$78,000
-4.9%
3,100
-6.3%
0.00%
-100.0%
Q3 2016$82,000
+30.2%
3,310
+6.8%
0.00%
Q2 2016$63,000
+34.0%
3,1000.0%0.00%
Q1 2016$47,000
+11.9%
3,100
-1.6%
0.00%
Q4 2015$42,000
-4.5%
3,1510.0%0.00%
Q3 2015$44,000
+22.2%
3,151
+5.0%
0.00%
Q1 2015$36,000
+44.0%
3,0000.0%0.00%
Q4 2014$25,000
-3.8%
3,0000.0%0.00%
Q3 2014$26,000
-21.2%
3,0000.0%0.00%
Q2 2014$33,000
+22.2%
3,0000.0%0.00%
Q1 2014$27,000
+17.4%
3,0000.0%0.00%
Q4 2013$23,000
+4.5%
3,0000.0%0.00%
Q3 2013$22,0003,0000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders